Select your current weight 286 pounds 130 175 220 265 310 355 395 440 Weight you could lose 57 pounds *In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
The weight loss achieved may be less dramatic than with surgery, and maintaining results requires lifestyle modifications and consistent medication
doi: 10.1056/nejmc1111038 139 DomnguezJIde AmestiMMajersonA
Every treatment plan is prescribed and monitored by a physician for safe, sustainable results
This genetic test examines key variants including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313, mapping 14 biological pathways and 150+ unique genetic insights that influence weight loss medication effectiveness
GLP-1 receptor agonists are prescription medications originally developed to treat type 2 diabetes